Tag: chemotherapy

Articles

• How to optimize your breast cancer diet
• Latest research concerning breast cancer in old age
• Latest research concerning side effects of chemotherapy
• Latest research on factors influencing Adriamycin (doxorubicin) effectiveness
• Latest research on factors influencing Taxol (paclitaxel) effectiveness
• Prognosis of triple negative breast cancer compared to other breast cancer subtypes
• To those who are thinking of using a raw food diet alone to treat breast cancer
• What should breast cancer patients eat during Adriamycin (doxorubicin) chemotherapy?
• What should breast cancer patients eat during Taxol (paclitaxel) chemotherapy?

News

• Adding the bisphosphonate zoledronic acid to chemotherapy does not improve outcome markers
• African-American and Latina women more likely to start chemotherapy late
• African-Americans receiving less optimal treatment for early-stage breast cancer
• Apigenin enhances the anticancer activity of 5-FU chemotherapy
• Apigenin increases effectiveness of Taxol chemotherapy
• Beta-carotene, vitamin A and vitamin E do not reduce risk of breast cancer?
• Black pepper may help prevent resistance to Adriamycin (doxorubicin) chemotherapy
• Brassica compound DIM inhibits breast cancer cell growth synergistically with Taxotere
• Breast cancer subtype influences prognosis after neoadjuvant chemotherapy
• Breast cancer survivors may experience brain changes similar to post traumatic stress
• Breast cancer treatment differences for foreign-born Hispanic women
• Caffeic acid phenethyl ester (CAPE), a component of propolis, inhibits breast cancer growth
• Caffeine may reduce the effectiveness of Adriamycin (doxorubicin) chemotherapy
• Can antioxidant supplements help prevent breast cancer?
• Chemo brain can persist for more than three years after breast cancer treatment
• Chemotherapy and radiation moderately suppress immune system
• Chemotherapy improves HER2+ and triple negative outcomes even for small (1cm) tumors
• Chemotherapy might cause chemo brain by disrupting the formation of brain nerve cells
• Chemotherapy might have different effectiveness in lobular compared to ductal breast cancer
• Chemotherapy resistance is accompanied by increase in number of breast cancer stem cells
• Chemotherapy results in measurable reductions in brain gray matter
• Coenzyme Q10 (CoQ10) might increase risk of postmenopausal breast cancer
• Curcumin reduces breast cancer resistance to treatment with Adriamycin (doxorubicin) chemotherapy
• Degree of chemo brain appears to be influenced by age and cognitive reserve
• Different receptor status in lymph nodes might explain some treatment failures
• DIM from broccoli and other brassica vegetables prevents metastasis in mice
• Does chemotherapy for breast cancer result in dementia in later years?
• Effectiveness of MRI in monitoring effectiveness of chemotherapy depends on subtype
• Fasting protects normal cells and sensitizes cancer cells to chemotherapy
• Fish oil component can increase survival time for Stage IV breast cancer patients
• Fish oil promotes breast cancer cell death
• Garlic reduces heart damage caused by doxorubicin chemotherapy
• Heavy exercise and other stressors might help cancer cells to survive treatment
• Herceptin has reduced locoregional recurrence for HER2+ compared to triple negative breast cancer
• Herceptin plus anthracycline chemotherapy greatly increases risk of heart damage
• Kaempferol protects against Adriamycin-induced heart damage
• Low white blood cell count as a result of chemotherapy indicates the treatment is working
• Modern chemotherapy reduces breast cancer death by about a third compared to no chemotherapy
• Muscle and joint pain are common during taxane chemotherapy for breast cancer
• Neutropenia during chemotherapy predicts favorable breast cancer outcome
• Non-anthracycline chemotherapy plus Herceptin is effective treatment for HER2+ breast cancer
• Old women tend to have less aggressive breast cancer and are given less treatment
• Pathological complete response after chemotherapy predicts favorable outcome
• Pomegranate compounds inhibit aromatase and reduces breast cancer cell proliferation
• Predictors of failure to respond to neoadjuvant chemotherapy
• Radiation treatment can result in persistent fatigue
• Residual cancer after chemotherapy
• Resistance to Taxol chemotherapy reversed in breast cancer cells in the laboratory
• Response to neoadjuvant chemotherapy depends on dosage and tumor type
• Resveratrol increases effectiveness of Taxotere (docetaxel) and Adriamycin (doxorubicin)
• Simultaneous chemotherapy plus radiation treatment reduces breast cancer recurrence
• Some fish oil supplements could interfere with effectiveness of chemotherapy
• Survival times for metastatic breast cancer have been improving
• Taking aspirin improves breast cancer survival
• Taking Celebrex might reduce the effectiveness of chemotherapy for breast cancer
• The beta blocker propranolol increases the effectiveness of Taxol
• The yellow vegetable pigment luteolin induces breast cancer cell death
• Triple negative breast cancer responds to treatments depending on gene expression
• Turmeric component curcumin enhances effectiveness of Adriamycin chemotherapy
• Turmeric component curcumin inhibits breast cancer cell proliferation
• Use of vitamin C and vitamin E is associated with less breast cancer recurrence

Foods

• açaí berries  apples  basil  black pepper  blueberries  broccoli  brussels sprouts  cabbage  cauliflower  celery  chamomile  cranberries  ginger  grape seed oil  grapefruit  green tea  greens  herring and sardines  honey  horseradish  kale  lemons  mackerel  mint  mustard  olives and olive oil  onions and garlic  paprika  parsley  peaches  pears  pineapple  saffron  sage  salmon  sesame seeds and sesame oil  shellfish  tomatoes  turmeric 

Studies

• 3, 3'-diindolylmethane enhances taxotere-induced growth inhibition of breast cancer cells through down-regulation of FoxM1
• 3,3' -diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells
• 5-Fluorouracil combined with apigenin enhances anticancer activity through induction of apoptosis in human breast cancer MDA-MB-453 cells
• A comprehensive evaluation of outcomes for inflammatory breast cancer
• Addition of Bevacizumab to Conventional Therapy Improved Progression-Free Survival in HER2-Positive Breast Cancer
• Addition of Trastuzumab May Potentially Equalize Disease-Free Survival Outcomes Among Obese and Normal-Weight Patients
• Adjuvant bisphosphonates in breast cancer: Are we witnessing the emergence of a new therapeutic strategy?
• Adjuvant chemotherapy and radiotherapy in triple-negative breast carcinoma: a prospective randomized controlled multi-center trial
• Adjuvant Trastuzumab in HER2-Positive Breast Cancer
• Aged Garlic Extract Protects against Doxorubicin-Induced Cardiotoxicity In Rats
• Antiemetic effect of ginger in gynecologic oncology patients receiving cisplatin
• Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort
• Antioxidants Suppress Apoptosis
• Antitumor activity of doxorubicin is enhanced by curcumin
• ANZAC: A Randomised Neoadjuvant Biomarker Study Investigating the Anti-Tumour Activity of the Addition of Zoledronic Acid to Chemotherapy in Breast Cancer
• Apigenin augments the growth inhibitory effects of doxorubicin in breast cancer cells derived from African American patients
• Attenuation of Cytotoxic Natural Product DNA Intercalating Agents by Caffeine
• Black-white differences in receipt and completion of adjuvant chemotherapy among breast cancer patients in a rural region of the US
• BRCA2 deficiency exaggerates doxorubicin-induced cardiomyocyte apoptosis and cardiac failure
• Breast cancer affects both the hippocampus volume and the episodic autobiographical memory retrieval
• Breast cancer in elderly women (at least 80 years): variation in standard of care?
• Breast Cancer Mortality Higher in Hispanic Women
• Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumors: being younger and getting less benefit from adjuvant tamoxifen treatment
• Cadmium influences the 5-Fluorouracil cytotoxic effects on breast cancer cells
• Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer
• Cardioprotective effect of curcumin against doxorubicin-induced myocardial toxicity in albino rats
• Cardiotoxic Chemotherapy is Associated with Increased Heart Failure Risk Among Women with Breast Cancer in the Cancer Research Network
• Cell proliferation of feline and human breast cancer cell types is inhibited by pomegranate juice
• Chemotherapy-induced amenorrhea: Predictive markers of response to neoadjuvant chemotherapy in breast cancer
• Cisplatin combination with allyl isothiocyanate, a constituent of cruciferous vegetables, synergistically increases cancer cell death through activation of caspase 3 and downregulation of the antiapoptotic protein Bcl-2 and survivin
• Classical lobular breast carcinoma consistently lacks topoisomerase-IIα gene amplification: implications for the tailored use of anthracycline-based chemotherapies
• Clinical outcome of triple-negative primary breast cancer in older women: Comparison with their younger counterparts
• Cognitive functioning after cancer treatment
• Comparison of locoregional recurrence in triple-negative and HER2-positive breast cancer subtype after breast-conserving therapy and modern systemic therapy
• Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
• Curcumin enhances the efficacy of chemotherapy by tailoring p65NFκB-p300 cross-talk in favor of p53-p300 in breast cancer
• Curcumin improves MMC-based chemotherapy by simultaneously sensitising cancer cells to MMC and reducing MMC-associated side-effects
• Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins
• Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model
• Curcumin Suppresses the Paclitaxel-Induced Nuclear Factor-[kappa]B in Breast Cancer Cells and Potentiates the Growth Inhibitory Effect of Paclitaxel in a Breast Cancer Nude Mice Model
• Decrease in breast density in the contralateral normal breast of patients receiving neoadjuvant chemotherapy: MR imaging evaluation
• Delays in Adjuvant Chemotherapy Treatment Among Patients With Breast Cancer Are More Likely in African American and Hispanic Populations: A National Cohort Study 2004-2006
• Differences in long-term survival for Hispanic and non-Hispanic white women with breast cancer
• Differential modulation of cisplatin and doxorubicin efficacies in leukemia cells by flavonoids
• Docosahexaenoic acid increases doxorubicin’s cytotoxicity against breast cancer cell lines
• Early identification of trastuzumab-related cardiotoxicity with speckle-tracking echocardiography
• Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer
• Effect of Selected Phytochemicals and Apple Extracts on NF-κB Activation in Human Breast Cancer MCF-7 Cells
• Effects of doxorubicin on brain activity and resting-state functional connectivity in rats: fMRI studies
• Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells
• Effects of quercetin on the bioavailability of doxorubicin in rats: Role of CYP3A4 and P-gp inhibition by quercetin
• Effects of the olive, extra virgin olive and canola oils on cisplatin-induced clastogenesis in Wistar rats
• Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancer
• Evaluation of the Antiproliferative Effects of Essiac™ on In Vitro and In Vivo Models of Prostate Cancer Compared to Paclitaxel
• Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy
• Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study
• Hematologic toxicity with adjuvant docetaxel and cyclophosphamide in early breast cancer
• Hepatotoxicity in breast cancer patients post-chemotherapy with docetaxel, doxorubucin, and cyclophosphamide
• High Prevalence of Vitamin D Deficiency Despite Supplementation in Premenopausal Women With Breast Cancer Undergoing Adjuvant Chemotherapy
• Higher Incidence of Venous Thromboembolism in the Outpatient Versus the Inpatient Setting Among U.S. Cancer Patients
• Hsp27 Protects Adenocarcinoma Cells from UV-Induced Apoptosis by Akt and p21-Dependent Pathways of Survival
• Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
• Impact of Adjuvant Chemo- and Radiotherapy on the Cellular Immune System of Breast Cancer Patients
• Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials
• Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial
• Incidence of reduced chemotherapy relative dose intensity among women with early stage breast cancer in US clinical practice
• Influence of comorbidities and age on risk of death without recurrence: a retrospective analysis of the Arimidex, Tamoxifen Alone or in Combination trial
• Influence of Garlic (Allium sativum) on the Pharmacokinetics of Docetaxel
• Interaction of celecoxib with different anti-cancer drugs is antagonistic in breast but not in other cancer cells
• Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro
• Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging
• Late pancreatic toxicity in patients with breast cancer after taxane-anthracycline-based neoadjuvant and adjuvant chemotherapy
• Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells
• Locoregional recurrence risk factors in breast cancer patients with positive axillary lymph nodes and the impact of postmastectomy radiotherapy
• Long-Term Outcomes in Stage IIIB Breast Cancer Patients Who Achieved Less Than a Pathological Complete Response After Primary Chemotherapy
• Longitudinal Assessment of Chemotherapy-Induced Structural Changes in Cerebral White Matter and Its Correlation With Impaired Cognitive Functioning
• Longitudinal Assessment of Cognitive Changes Associated With Adjuvant Treatment for Breast Cancer: Impact of Age and Cognitive Reserve
• Luteolin as a glycolysis inhibitor offers superior efficacy and lesser toxicity of doxorubicin in breast cancer cells
• Luteolin induces apoptosis in multidrug resistant cancer cells without affecting the drug transporter function: involvement of cell line-specific apoptotic mechanisms
• Magnetic Resonance Imaging Response Monitoring of Breast Cancer During Neoadjuvant Chemotherapy: Relevance of Breast Cancer Subtype
• Management of Operable Invasive Breast Cancer in Women Over the Age of 70: Long-Term Results of a Large-Scale Single-Institution Experience
• Mesenchymal Stem Cells Induce Resistance to Chemotherapy through the Release of Platinum-Induced Fatty Acids
• Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients
• Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
• Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
• Moderate neutropenia with adjuvant CMF confers improved survival in early breast cancer
• Modulation of multidrug resistance and apoptosis of cancer cells by selected carotenoids
• Molecular Class as a Predictor of Locoregional and Distant Recurrence in the Neoadjuvant Setting for Breast Cancer
• Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer
• Muscle and Joint Symptoms in Breast Cancer Patients Receiving Taxane-Based Chemotherapy
• Neoadjuvant Chemotherapy Increases the Rate of Breast Conservation in Lobular-Type Breast Cancer Patients
• New model system for testing effects of flavonoids on doxorubicin-related formation of hydroxyl radicals
• Oral Bisphosphonate Did Not Improve Prognosis for Patients With Breast Cancer
• Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer
• Patterns of Local and Distant Disease Relapse in Patients with Breast Cancer Treated with Primary Chemotherapy: Do Patients with a Complete Pathological Response Differ from Those with Residual Tumour in the Breast?
• Piperine, a piperidine alkaloid from Piper nigrum re-sensitizes P-gp, MRP1 and BCRP dependent multidrug resistant cancer cells
• Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score
• Predictive role of molecular subtypes in response to neoadjuvant chemotherapy in breast cancer patients in northeast china
• Predictors of timing of adjuvant chemotherapy in older women with hormone receptor-negative, stages II-III breast cancer
• Predictors of Tumor Progression During Neoadjuvant Chemotherapy in Breast Cancer
• Prefrontal Cortex and Executive Function Impairments in Primary Breast Cancer
• Prognosis and Outcome of Small (1 cm), Node-Negative Breast Cancer on the Basis of Hormonal and HER-2 Status
• Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer
• Prognostic Significance of Neutropenia on Day One of Anthracycline-Based Neoadjuvant Chemotherapy in Operable Breast Cancer
• Prognostic value of chemotherapy-induced neutropenia in early-stage breast cancer
• Protective effect of saffron (Crocus sativus L.) aqueous extract against genetic damage induced by anti-tumor agents in mice
• Racial variation in breast cancer treatment among department of defense beneficiaries
• Relationship Between Chemotherapy Use and Cognitive Impairments in Older Women With Breast Cancer: Findings From a Large Population-Based Cohort
• Response to influenza virus vaccination during chemotherapy in patients with breast cancer
• Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer: Results from the GeparQuattro study (GBG 40)
• Resveratrol enhances the cytotoxic profile of docetaxel and doxorubicin in solid tumour cell lines in vitro
• Risk Factors of Developing Long-Lasting Breast Pain After Breast Cancer Radiotherapy
• Sequence of Radiotherapy and Chemotherapy in Breast Cancer After Breast-Conserving Surgery
• Serum Molecular Signatures of Weight Change during Early Breast Cancer Chemotherapy
• Severe dietary restriction enhances cancer treatment: Protecting normal cells and sensitizing malignant cells to chemotherapy by fasting
• Small node-negative (T1b-cN0) invasive hormone receptor-positive breast cancers: Is there a subpopulation that might have benefit from adjuvant chemotherapy?
• Synchronous Chemo-radiation Can Reduce Local Recurrence in Early Stage Breast Cancer: Results of the SECRAB Trial
• Synergistic Effects of Apigenin and Paclitaxel on Apoptosis of Cancer Cells
• Targeting breast stem cells with the cancer preventive compounds curcumin and piperine
• The dark side of curcumin
• The effects of exercise training on antitumor efficacy of doxorubicin in MDA-MB-231 breast cancer xenografts
• The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials
• The extract of Prunus persica flesh (PPFE) attenuates chemotherapy-induced hepatotoxicity in mice
• The herbal medicine black cohosh increases the cytotoxicity of doxorubicin to breast cancer cells by inhibiting doxorubicin efflux
• The Longitudinal Relationship between Fatigue and Sleep in Breast Cancer Patients Undergoing Chemotherapy
• The prognostic impact of age in patients with triple-negative breast cancer
• The Role of Curcuma longa Against Doxorubicin (Adriamycin)-Induced Toxicity in Rats
• The role of neurogenesis in post-chemotherapy cognitive impairment
• Timing of re-excision surgery (S2) for positive margins (PM) and initiation of adjuvant systemic treatment (aRx) in early breast cancer patients (BC pts)
• Triple-Negative Breast Cancer: An Update on Neoadjuvant Clinical Trials
• Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
• Vitamin D Deficiency Promotes Human Breast Cancer Growth in a Murine Model of Bone Metastasis
• Warburg effect in chemosensitivity: Targeting lactate dehydrogenase-A re-sensitizes Taxol-resistant cancer cells to Taxol
• Weight change during adjuvant chemotherapy regimens for breast cancer